T 1875/18 (Apixaban/BRISTOL-MYERS) of 07.05.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T187518.20210507
- Date of decision
- 7 May 2021
- Case number
- T 1875/18
- Petition for review of
- -
- Application number
- 11707284.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- APIXABAN FORMULATIONS
- Applicant name
- Bristol-Myers Squibb Company
Pfizer Inc. - Opponent name
- Teva Pharmaceutical Industries Ltd
Plougmann Vingtoft a/s
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
STADA Arzneimittel AG
KRKA, d.d., Novo mesto
Galenicum Health S.L.U.
Generics (U.K.) Limited
Hamm&Wittkopp Patentanwälte PartmbB
Intas Pharmaceuticals Ltd.
LEK Pharmaceuticals d.d.
Zentiva k.s. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)
- Keywords
- Amendments - intermediate generalisation
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The appeal is dismissed.